-
Pfizer: This Biotech Blue-Chip Offers Market-Beating Total Return Potential
Post on 3/14/19
-
Harmony Biosciences Secures $200 Million Debt Facility
Post on 3/13/19
-
Merck GHIF Leads $40M Series D For TriNetX
Post on 3/13/19
-
Trevena Reports Fourth Quarter and Full Year 2018 Results
Post on 3/13/19
-
Why Johnson & Johnson Is Still An Attractive Investment
Post on 3/13/19
-
Amneal Announces Launch of Rivastigmine Transdermal System
Post on 3/12/19
-
Fidia Pharma USA Announces Expansion into Regenerative Medicine Markets with Launch of NuDYN
Post on 3/17/19
-
Advaxis Reports First Quarter Fiscal 2019 Financial Results and Provides Clinical Pipeline Update
Post on 3/12/19
-
J&J's Stelara Shows Positive Action In Late-Stage UC Study
Post on 3/12/19
-
Lannett Enters Into Distribution Agreement For Generic Adderall
Post on 3/11/19
-
Marinus Pharmaceuticals Provides Business Update
Post on 3/11/19
-
Better Buy: Abbott Laboratories vs. Johnson & Johnson
Post on 3/11/19
-
Johnson & Johnson: Brace For Impact
Post on 3/8/19
-
Celgene-Bristol: Deal Or No Deal?
Post on 3/7/19
-
Quest Diagnostics Prices $500 Million of Senior Notes
Post on 3/7/19
-
Celldex Provides Corporate Update
Post on 3/7/19
-
Philly’s Ranks 8th Among the Country’s Top Life Sciences Clusters
Post on 3/7/19
-
American Medical & Dental Supplies Announces the Launch of Its New Web Site
Post on 3/7/19
-
Why Teva Pharmaceutical Industries Stock Sank in February
Post on 3/7/19
-
FDA OKs J&J's Esketamine Nasal Spray For Depression
Post on 3/6/19
-
If The Celgene Deal Fails, Who Would Buy Bristol-Myers Squibb?
Post on 3/6/19
-
Better Buy: Walmart vs. Rite Aid
Post on 3/6/19
-
Smart Health Innovation Lab Accepts OneOme to Its Certification Program
Post on 3/21/19
-
Neuronetics Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
Post on 3/5/19
-
Merck Begins Tender Offer to Acquire Immune Design
Post on 3/5/19